Q1: 2026-04-28 Earnings Summary
EPS of $0.34 beats by $0.21
| Revenue of $117.70M (38.99% Y/Y) beats by $13.25M
CareDx, Inc. (CDNA) Q1 2026 Earnings Call April 28, 2026 4:30 PM EDT
Company Participants
Caroline Corner – Investor Relations
John Hanna – President, CEO & Director
Jeffrey Teuteberg – Chief Medical Officer
Keith Kennedy – CFO & COO
Conference Call Participants
Brandon Couillard – Wells Fargo Securities, LLC, Research Division
Mark Massaro – BTIG, LLC, Research Division
Andrew Brackmann – William Blair & Company L.L.C., Research Division
Mason Carrico – Stephens Inc., Research Division
John Wilkin – Craig-Hallum Capital Group LLC, Research Division
Tom DeBourcy – Nephron Research LLC
Presentation
Operator
Hello, everyone. Thank you for joining us, and welcome to CareDx Q1 2026 Financial Results Earnings Call. [Operator Instructions] I will now hand the conference over to Caroline Corner, Investor Relations. Caroline, please go ahead.
Caroline Corner
Investor Relations
Thank you, operator. Good afternoon. Thank you for joining us today. Earlier today, CareDx released financial results for the first quarter of 2026 ending March 31, 2026. The results are currently available on the company’s website at www.caredx.com. Joining me on today’s call are John Hanna, President and Chief Executive Officer; Keith Kennedy, Chief Operating Officer and Chief Financial Officer; and Dr. Jeffrey Teuteberg, Chief Medical Officer.
Before we get started, I would like to remind everyone that management will be making statements during this call that include forward-looking statements. Any statements contained in this call that are not statements of historical facts should be deemed to be forward-looking statements. All forward-looking statements are based upon current estimates and various assumptions. These statements involve material risks and uncertainties that could cause actual results to differ materially from those anticipated or implied by these forward-looking statements.
Accordingly, you should not place undue reliance on these statements. Information concerning the risks, uncertainties and other factors that could cause results to differ from these forward-looking statements is included in our filings











